The What Who Why And How Of Cataracts Ic 8 Lens

The What Who Why And How Of Cataracts Ic 8 Lens The ic 8 apthera iol is used in adults who have cataracts, need eye surgery, and have only a small amount (1.5 diopters or less) of abnormal curve to the cornea (astigmatism). Acufocus inc. today announced the fda has approved its ic 8 apthera iol for the treatment of cataracts. the apthera iol is the first and only non toric extended depth of focus iol approved for the 82% of cataract patients who have as much as 1.5 d of corneal astigmatism. 2. al waterhouse, president and ceo for acufocus, said the company was.

The What Who Why And How Of Cataracts Ic 8 Lens The ic 8 iol is capable of providing extended depth of focus following cataract surgery. it allows complete spectacle independence in more than half of the patients implanted with the ic 8 iol. The acufocus ic 8 intraocular lens extends depth of focus by combining small aperture technology with a monofocal lens. this innovative design – incorporating an opaque mini ring with a central aperture – provides cataract patients with excellent quality of vision over a broad range of distances. expert panel of ophthalmic surgeons. At the same time, the ic 8 iol avoids typical issues associated with multifocal lens designs while improving vision quality in a range of patients. cases that benefit from the ic 8 iol include traditional cataract eyes, patients with a successful history with monovision, eyes with a high risk of a missed refractive target, and those who do not. Using small aperture technology, vision is improved without splitting, shifting or stretching light, providing an uninterrupted range of vision for cataract patients. 82% of all cataract patients are present with 1.5d of corneal astigmatism of less. 1 the apthera iol delivers excellent results in patients with up to 1.5d of corneal astigmatism.